HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heiko Herwald Selected Research

Necrotizing Fasciitis

1/2018Leucocyte recruitment and molecular fortification of keratinocytes triggered by streptococcal M1 protein.
12/2015Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo.
9/2011Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense.
7/2010M1 protein from streptococcus pyogenes induces nitric oxide-mediated vascular hyporesponsiveness to phenylephrine: involvement of toll-like receptor activation.
9/2009Neutrophil-derived hyperresistinemia in severe acute streptococcal infections.
2/2004M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heiko Herwald Research Topics

Disease

22Infections
01/2019 - 02/2004
15Sepsis (Septicemia)
08/2021 - 06/2002
12Inflammation (Inflammations)
01/2019 - 08/2002
11Edema (Dropsy)
06/2015 - 01/2011
9Streptococcal Infections (Streptococcal Infection)
11/2012 - 02/2004
8Lung Injury
01/2019 - 01/2011
7Septic Shock (Toxic Shock Syndrome)
08/2021 - 09/2008
7Acute Lung Injury
01/2019 - 06/2011
6Bacterial Infections (Bacterial Infection)
12/2019 - 08/2003
6Shock
01/2019 - 10/2009
6Pneumonia (Pneumonitis)
01/2018 - 01/2011
6Necrotizing Fasciitis
01/2018 - 02/2004
5Communicable Diseases (Infectious Diseases)
03/2020 - 08/2007
3Leptospirosis
01/2019 - 08/2010
3Cystic Fibrosis (Mucoviscidosis)
01/2018 - 01/2017
3Thrombosis (Thrombus)
01/2018 - 06/2011
3Hemolysis
01/2018 - 12/2010
3Critical Illness (Critically Ill)
02/2016 - 01/2013
2Wounds and Injuries (Trauma)
01/2020 - 01/2014
2Burns
01/2019 - 12/2009
2Endocarditis
01/2018 - 06/2002
2Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 01/2016
1Pancreatitis
08/2021
1Asthma (Bronchial Asthma)
01/2019
1Heart Arrest (Cardiac Arrest)
01/2019
1Pneumococcal Infections
01/2019
1Soft Tissue Infections
01/2018
1Bacterial Meningitis
01/2018
1Gram-Negative Bacterial Infections
01/2018
1Cellulitis
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Atherosclerosis
01/2017
1Reperfusion Injury
01/2017
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2017
1Pathologic Processes
10/2015
1Disseminated Intravascular Coagulation
10/2015
1Thrombocytopenia (Thrombopenia)
01/2014
1Respiratory Insufficiency (Respiratory Failure)
01/2013

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2004
13human AZU1 proteinIBA
08/2021 - 08/2004
10CXC ChemokinesIBA
06/2015 - 06/2011
5BradykininIBA
01/2019 - 11/2008
5Histones (Histone)IBA
01/2019 - 01/2014
5Peptides (Polypeptides)IBA
01/2018 - 07/2009
4Biomarkers (Surrogate Marker)IBA
08/2021 - 08/2010
4Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 06/2011
4Chemotactic FactorsIBA
01/2019 - 12/2008
3OsteopontinIBA
01/2019 - 01/2016
3FibrinIBA
01/2018 - 06/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2017
3KininsIBA
02/2011 - 08/2002
2Hemostatics (Antihemorrhagics)IBA
01/2019 - 01/2016
2High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
12/2018 - 07/2009
2Deoxyribonucleases (DNase)FDA Link
01/2018 - 01/2017
2Virulence Factors (Pathogenicity Factors)IBA
01/2018 - 01/2018
2ResistinIBA
02/2016 - 09/2009
2CoagulantsIBA
01/2016 - 01/2013
2ChemokinesIBA
06/2015 - 02/2010
2Fibrinogen (Factor I)FDA Link
04/2015 - 02/2004
2Simvastatin (Zocor)FDA LinkGeneric
07/2013 - 06/2011
2Complement System Proteins (Complement)IBA
12/2010 - 08/2003
2AnticoagulantsIBA
02/2010 - 09/2007
1HepcidinsIBA
01/2020
1IronIBA
01/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2020
1Local Anti-Infective Agents (Antiseptics)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
12/2019
1AntithrombinsIBA
12/2019
1AllergensIBA
01/2019
1LipopolysaccharidesIBA
01/2019
1EndotoxinsIBA
01/2018
1Cell-Free Nucleic AcidsIBA
01/2018
1tissue-factor-pathway inhibitor 2 (PP5)IBA
01/2018
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1Lipopolysaccharide ReceptorsIBA
01/2018
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1AntigensIBA
01/2018
1Bacterial Proteins (Bacterial Protein)IBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1RNA (Ribonucleic Acid)IBA
01/2017
1Nucleic AcidsIBA
01/2017
1LactamsIBA
01/2017
1QuinolonesIBA
01/2017
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2017
1EM703IBA
01/2017
1MacrolidesIBA
01/2017
1Glycoproteins (Glycoprotein)IBA
01/2016
1ThrombinFDA Link
10/2015
1NSC 74859IBA
06/2015
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2013
1GGTI-2133IBA
03/2013
1TransferasesIBA
03/2013
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2013

Therapy/Procedure

4Critical Care (Surgical Intensive Care)
12/2018 - 09/2008
1Therapeutics
03/2020
1Oral Administration
07/2013